Gilead prices COVID-19 drug remdesivir at $2,340 per patient
Remdesivir is expected to be in high demand as one of the only treatments so far shown to alter the course of COVID-19.
Vials of investigational coronavirus disease (COVID-19) treatment drug are capped at a facility.(photo credit: GILEAD SCIENCES INC/HANDOUT VIA REUTERS)ByREUTERS
